16:51 EST Inhibikase Therapeutics (IKT) files to sell 58.31M shares of common stock for holders
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IKT:
- Inhibikase Therapeutics Reports Q3 2024 Financial Results
- Inhibikase Therapeutics reports Q3 EPS (65c), consensus (48c)
- Inhibikase Therapeutics, Inc. (IKT) Q3 Earnings Cheat Sheet
- Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
- Inhibikase Therapeutics initiated with a Buy at Jefferies